KAREN BORDEN: Open Payments
NPI 1548347982 · WEYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,315 in 93 payments from 18 companies in 2025. Trend: 2023 $2,571 · 2024 $2,868 · 2025 $2,315
Food & beverage: $2,306Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $387 |
| GENZYME CORPORATION | 5 | $316 |
| Galderma Laboratories, L.P. | 16 | $290 |
| ABBVIE INC. | 10 | $231 |
| LEO Pharma Inc. | 5 | $137 |
| Incyte Corporation | 4 | $116 |
| Amgen Inc. | 4 | $114 |
| Regeneron Healthcare Solutions, Inc. | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $101 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, ADBRY, OPZELURA, Otezla, COSENTYX.
Industry payments across MA — which companies pay providers there.
